XML 28 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Note 14 - Taxes
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Taxes

Note 14 – Taxes

Income tax expense during interim periods is based on applying an estimated annual effective income tax rate to year-to-date income, plus any significant unusual or infrequently occurring items, such as the net gain on change in fair value of debt held under the fair value option, which are recorded in the interim period. The provision for income taxes for the three months ended March 31, 2024 and 2023 reflects an income tax (expense) benefit of $(0.1) million and approximately $1.7 million, respectively, at an estimated annual effective tax rate of (0.4)% and 23.1%, respectively. The difference between the Company’s effective tax rate and the federal statutory rate is primarily due to the loss attributable to the Operating Partnership and net gain on change in fair value of debt held under the fair value option, each of which is not subject to tax and state income taxes and the fact the Company had a full valuation as of March 31, 2024 and December 31, 2023. As of March 31, 2024, the Company maintained a full valuation allowance on its deferred tax assets as the timing of the utilization of its net operating losses is uncertain. For the three months ended March 31, 2024, the Company recorded a valuation allowance of $1.7 million against the deferred tax asset, respectively.